Abstract
The present study aimed at assessing the frequency ofHFE mutations (C282Y, H63D and S65C) in western Romanian patients with liver disease of diverse aetiologies suspected of iron overload. A total of 21 patients, all Romanian residents hospitalized with clinical suspicion of iron overload and liver disease, were assayed for C282Y, H63D and S65C mutations, serum ferritin and viral hepatitis markers. Overall, 9 out of the 21 patients (42.86%) were found to harbour mutations in theHFE gene: 4 homozygotes C282Y (19.0%), 1 compound heterozygote C282Y/H63D (4.8%), 1 single heterozygote C282Y (4.8%), 2 single heterozygotes H63D (9.5%), 1 single heterozygote S65C (4.8%), and 12 wild-type cases (57.1%). Among the subgroup of 10 patients with the most prominent signs of iron overload (hyperferritinaemia and/or hepatocyte iron score ≥ 1), without hepatocellular carcinoma, theHFE genotypes were conclusive in 5 cases (50%). They had significantly increased ferritin levels compared to wild-type cases (P = 0.029). The inclusion of iron studies during routine clinical visits, coupled with the availability ofHFE genotyping for family and population studies, should facilitate the early detection of hereditary haemochromatosis in Romania.
This is a preview of subscription content, log in via an institution to check access.
References
Adams PC, Reboussin DM, Press RD, Barton JC, Acton RT, Moses GC, et al. 2007. Biological Variability of Transferrin Saturation and Unsaturated Iron-Binding Capacity. Am J Med 120: 999.e1–999.e7.
Bollhalder M, Mura C, Landt O, Maly FE, 1999. LightCycler PCR assay for simultaneous detection of the H63D and S65C mutations in theHFE hemochromatosis gene based on opposite melting temperature shifts. Clin Chem 45: 2275–2278.
Brissot P, Troadec MB, Bardou-Jacquet E, Le Lan C, Jouanolle AM, Deugnier Y, et al. 2008. Current approach to hemochromatosis. Blood Rev 22: 195–210.
Ellervik C, Birgens H, Tybjćrg-Hansen A, Nordestgaard BG, 2007. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls. Hepatology 46: 1071–1080.
Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. 1996. Anovel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13: 399–408.
Feeney GP, Worwood M, 2001. The effects of wild-type and mutant HFE expression upon cellular iron uptake in transfected human embryonic kidney cells. Biochim Biophys Acta 1538: 242–251.
Jeffrey GP, Chakrabarti S, Hegele RA, Adams PC, 1999. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nat Genet 22: 325–326.
Mangasser-Stephan K, Tag C, Reiser A, Gressner AM, 1999. Rapid genotyping of hemochromatosis gene mutations on the LightCycler with fluorescent hybridization probes. Clin Chem 45: 1875–1878.
Ropero P, Llorente L, González FA, Briceńo O, Mateo M, Polo M, et al. 2007. Incidence of theHFE gene mutations in a cohort of non-Spanish origin neonates in Madrid. Ann Hematol 86: 459–462.
Šarić M, Zamurović L, Kekarević-Marković M, Kekarević D, Stevanović M, Savić-Pavićević D, et al. 2006. Frequency of the hemochromatosis gene mutations in the population of Serbia and Montenegro. Clin Genet 70: 170–172.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Neghina, A.M., Anghel, A., Sporea, I. et al. MutantHFE genotype leads to significant iron overload in patients with liver diseases from western Romania. J Appl Genet 50, 173–176 (2009). https://doi.org/10.1007/BF03195670
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03195670